Immuneering Corporation
IMRX | NASDAQ
$4.64
+$0.20 (+4.50%)
Sep 22, 2026, 11:26 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 128.65M | 36.14M | 59.41M | 72.64M | 74.89M | 37.09M |
Short-Term Investments | 44.19M | n/a | 26.26M | 32.89M | 74.31M | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 996.56K | n/a |
Other Long-Term Assets | 44.47M | 1.3M | 1.03M | 743.7K | 102.13K | 14.33K |
Receivables | n/a | n/a | n/a | 12.42K | 246.04K | 500.11K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.41M | 3.44M | 3.42M | 3.21M | n/a | n/a |
Total Current Assets | 176.25M | 39.59M | 89.08M | 108.75M | 152.33M | 37.73M |
Property-Plant & Equipment | 4.26M | 4.79M | 5.4M | 5.78M | 6.13M | 677.47K |
Goodwill & Intangibles | 7.01M | 7.04M | 7.07M | 7.1M | 7.14M | n/a |
Total Long-Term Assets | 55.74M | 13.13M | 13.5M | 13.62M | 14.37M | 691.8K |
Total Assets | 231.99M | 52.71M | 102.58M | 122.37M | 166.7M | 38.42M |
Account Payables | 1.54M | 1.96M | 2.11M | 3.15M | 1.39M | 1.48M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 4.54M | 3.82M | 3.89M | 3.65M | 2.92M | 163.67K |
Total Current Liabilities | 10.07M | 7.5M | 7.85M | 8.05M | 5.63M | 2.26M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 58.1M |
Total Long-Term Liabilities | 3.43M | 3.82M | 4.16M | 4.46M | 5.09M | 58.65M |
Total Liabilities | 13.5M | 11.33M | 12.01M | 12.52M | 10.72M | 60.9M |
Total Debt | 3.82M | 4.16M | 4.46M | 4.84M | 5.36M | 621.09K |
Book Value | 218.48M | 41.39M | 90.58M | 109.85M | 155.98M | -22.48M |
Book Value Per Share | 4.96 | 1.38 | 3.19 | 4.16 | 5.93 | -1.66 |
Common Stock | 64.65K | 31.05K | 29.27K | 26.42K | 26.32K | 4.95K |
Retained Earnings | -280.32M | -224.3M | -163.26M | -109.79M | -59.27M | -25.74M |
Comprehensive Income | 81.33K | n/a | -778 | -30.12K | -49.01K | n/a |
Shareholders Equity | 218.48M | 41.39M | 90.58M | 109.85M | 155.98M | -22.48M |
Total Investments | 44.19M | n/a | 26.26M | 32.89M | 75.31M | n/a |
Add to Watchlist
Select watchlists to add or remove IMRX